FindTrial
Sign In

Contrast sensitivity in CSR

Pattern of Contrast Sensitivity Changes in Acute Central Serous Chorioretinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20140515003
Enrollment
Unknown
Registered
2014-05-15
Start date
2014-05-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central serous chorioretinopathy (CSR) Central serous chorioretinopathy (CSR) contrast sensitivity

Interventions

Data of VA&#44
contrast sensitivity&#44
and disease progression were recorded at baseline&#44
1 month and 3 months later.
Treatment
Observational group

Sponsors

Faculty of Medicine, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Acute CSR with a new onset within 2 months

Exclusion criteria

Exclusion criteria: - Recurrent acute CSR with poor vision - Previous acute CSR in the fellow eye with suboptimal visual outcome - History of other retinal disease - Previous ocular surgery within 6 months - History of macular laser treatment - Significant ocular media opacity - Steriod use - Pregnancy - Allergic to fluorescien dye

Design outcomes

Primary

MeasureTime frame
Contrast sensitivity 0, 1, 3 months contrast sensitivity scores—

Secondary

MeasureTime frame
Visual acuity 0, 1, 3 months Snellen score—

Countries

Thailand

Contacts

Public ContactPatama Bhurayanontachai

Faculty of Medicine, Prince of Songkla University

patama103@yahoo.com.au6674451380

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026